News for 'Dr Reddy'

Three Indians who revolutionised medicines in the world

Three Indians who revolutionised medicines in the world

Rediff.com30 Mar 2013

Yusuf Hamied, Anji Reddy and Parvinder Singh are the real pioneers of the Indian pharmaceutical industry.

Market selloff: Investors lose Rs 6.15 lakh crore in 3 days

Market selloff: Investors lose Rs 6.15 lakh crore in 3 days

Rediff.com29 Oct 2021

Investors' wealth has eroded by over Rs 6.15 lakh crore in three days of market decline amid weak global cues and persistent selling by foreign funds. The BSE benchmark Sensex tumbled for the third straight session on Friday to close at 59,306.93, down 677.77 points or 1.13 per cent. In three days, the 30-share index has lost 2,043.33 points or 3.33 per cent.

Now, A Tirupati Balaji Temple In Jammu

Now, A Tirupati Balaji Temple In Jammu

Rediff.com9 Jun 2023

Spread over 62 acres of land, the temple has been built at an approximate cost of Rs 25 crores and the construction was completed in two years.

Prestigious South Chennai LS seat to see fierce triangular fight, here is why

Prestigious South Chennai LS seat to see fierce triangular fight, here is why

Rediff.com24 Mar 2024

Incumbent DMK MP T Sumathy alias Tamizhachi Thangapandian will face-off former Telangana Governor and BJP leader Tamilisai Soundararajan, while the the AIADMK has fielded ex-MP Dr J Jayavardhan, who won from here in 2014.

Sensex rallies 661 points on gains in auto, financials

Sensex rallies 661 points on gains in auto, financials

Rediff.com13 Apr 2021

M&M was the top gainer in the Sensex pack, rallying around 8 per cent, followed by Bajaj Finserv, Bajaj Finance, Maruti, Axis Bank, ONGC and HDFC Bank. NSE Nifty surged 194 points to 14,504.80.

Top 5 Moments in India-Australia T20 History

Top 5 Moments in India-Australia T20 History

Rediff.com22 Nov 2023

Let's delve into India's T20I track record against Australia

Investors richer by over Rs 5.77 lakh cr as markets rally

Investors richer by over Rs 5.77 lakh cr as markets rally

Rediff.com21 Jun 2022

Equity investors became richer by over Rs 5.77 lakh crore on Tuesday, helped by a rally in the broader market where the BSE benchmark jumped nearly 2 per cent. The BSE Sensex zoomed 934.23 points or 1.81 per cent to settle at 52,532.07. Driven by the rally in equities, the market capitalisation of BSE-listed firms jumped by Rs 5,77,006.83 crore to stand at Rs 2,40,63,930.50 crore. "Absence of fresh selling triggers in the domestic and global economy along with falling commodity prices relieved the heavily discounted equity market to showcase recovery.

'The Purest Love I've Ever Known'

'The Purest Love I've Ever Known'

Rediff.com13 May 2024

Star mums celebrate Mother's Day with cute pictures of their children.

Sensex rallies 958 points to end at new lifetime high of 59,885

Sensex rallies 958 points to end at new lifetime high of 59,885

Rediff.com23 Sep 2021

Bajaj Finserv was the top gainer in the Sensex pack, rising over 4 per cent, followed by L&T, HDFC, Axis Bank, SBI, Reliance Industries and IndusInd Bank. NSE Nifty soared 276.30 points to its new closing peak of 17,823.

Sensex surges 584 points; private banks rally

Sensex surges 584 points; private banks rally

Rediff.com9 Mar 2021

Kotak Bank was the top gainer in the Sensex pack, rising around 3 per cent, followed by HDFC twins, ICICI Bank, Tech Mahindra, Bajaj Finance, Asian Paints and TCS. NSE Nifty surged 142.20 points to 15,098.40.

Markets decline for 3rd day as HDFC Bank, TCS slide

Markets decline for 3rd day as HDFC Bank, TCS slide

Rediff.com25 Mar 2022

From the 30-share pack, Titan, Tech Mahindra, Maruti Suzuki India, Wipro, Nestle India, TCS, Larsen & Toubro, HCL Technologies, Tata Steel and HDFC Bank were among the major laggards. NSE Nifty declined 69.75 points to settle at 17,153.

Sensex ends down 89 points in choppy trade

Sensex ends down 89 points in choppy trade

Rediff.com24 Mar 2022

Benchmark stock indices Sensex and Nifty closed with losses in highly volatile trade on Thursday as banking and financial stocks retreated amid a weak trend in global equity markets. The 30-share BSE Sensex declined 89.14 points or 0.15 per cent to settle at 57,595.68. During the day, it touched a low of 57,138.51 and a high of 57,827.99. The broader NSE Nifty dipped 22.90 points or 0.13 per cent to settle at 17,222.75.

HDFC twins, Infosys drag Sensex down 304 points

HDFC twins, Infosys drag Sensex down 304 points

Rediff.com23 Mar 2022

Paring its early gains, benchmark BSE Sensex fell by 304 points on Wednesday as investors booked profit after recent gains amid concerns over inflation and supply constraints. Despite a firm start, the 30-share BSE barometer declined by 304.48 points or 0.53 per cent to settle at 57,684.82. During the day, it tanked 420.71 points or 0.72 per cent to 57,568.59.

Grief and shock in Hyderabad

Grief and shock in Hyderabad

Rediff.com3 Sep 2009

The untimely death of Andhra Pradesh Chief Minister Y S Rajasekhara Reddy has plunged the state into mourning.

Is A Vaccine Booster Needed?

Is A Vaccine Booster Needed?

Rediff.com20 Dec 2021

'There is no emergency of a third wave that we are rushing for booster doses.'

Sensex reclaims 50,000-level; auto, IT stocks shine

Sensex reclaims 50,000-level; auto, IT stocks shine

Rediff.com2 Mar 2021

On the Sensex chart, M&M, NTPC, Bajaj Auto, Tech Mahindra, TCS and Maruti emerged as top gainers. NSE Nifty climbed 157.55 points to settle at 14,919.10.

Sensex tanks 587 points; HDFC Bank slumps over 3%

Sensex tanks 587 points; HDFC Bank slumps over 3%

Rediff.com19 Jul 2021

HDFC Bank was the top loser in the Sensex pack followed by IndusInd Bank, Axis Bank, HDFC, Maruti and Bajaj Finance. NSE Nifty fell 171 points to 15,752.40.

Russia's Sputnik Light vaccine gets phase 3 SEC trial nod

Russia's Sputnik Light vaccine gets phase 3 SEC trial nod

Rediff.com15 Sep 2021

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation has recommended the conduct of Phase III clinical trials of Russia's single dose COVID-19 vaccine Sputnik Light.

B-Schools: Consulting Tops Interns Hires

B-Schools: Consulting Tops Interns Hires

Rediff.com9 Nov 2022

...followed by financial services, IT, and sales and marketing.

Positive economic data lift Sensex by 397 points

Positive economic data lift Sensex by 397 points

Rediff.com13 Jul 2021

ICICI Bank was the top gainer in the Sensex pack, surging nearly 3 per cent, followed by HDFC, Axis Bank, Sun Pharma, NTPC and M&M. NSE Nifty surged 119.75 points to 15,812.35.

Investors richer by over Rs 13.16 lakh cr in five days of market rally

Investors richer by over Rs 13.16 lakh cr in five days of market rally

Rediff.com14 Mar 2022

Investors' wealth has swelled by over Rs 13.16 lakh crore as benchmark indices continued their northward march for the fifth session on the trot on Monday. The 30-share BSE Sensex jumped 935.72 points or 1.68 per cent to settle at 56,486.02 on Monday. In the past five trading sessions, the benchmark has zoomed 3,643.27 points or 6.89 per cent. Propelled by the optimism in equities, the market capitalisation of BSE-listed firms jumped by Rs 13,16,944.74 crore in five trading sessions to Rs 2,54,27,775.78 crore.

Banking, IT counters help Sensex zoom 936 points

Banking, IT counters help Sensex zoom 936 points

Rediff.com14 Mar 2022

Equity benchmark Sensex rallied 936 points on Monday, helped by heavy buying in banking and IT counters along with decline in oil prices amid hopes of headway in renewed diplomatic talks between Russia and Ukraine. A fresh round of talks is expected on Monday between Ukrainian and Russian officials. Rising for the fifth straight session, the BSE Sensex jumped 935.72 points or 1.68 per cent to settle at 56,486.02.

Sensex reclaims 60k, Nifty tops 18k-mark

Sensex reclaims 60k, Nifty tops 18k-mark

Rediff.com31 Oct 2022

The Sensex finished above the psychologically key 60,000-mark while the Nifty surged past the 18,000-level on Monday on across-the-board buying amid a mixed trend overseas. A depreciating rupee and concerns over the US Federal Reserve hiking rates later this week failed to quell investors' appetite for stocks, traders said. The 30-share BSE Sensex rallied 786.74 points or 1.31 per cent to settle at 60,746.59.

Till the end he remained a man of the masses

Till the end he remained a man of the masses

Rediff.com3 Sep 2009

The 60-year-old Y S Rajasekhara Reddy's untimely death in a helicopter crash has robbed Andhra Pradesh, and the Congress party, of a charismatic leader

India business to put a spring in pharma's step

India business to put a spring in pharma's step

Rediff.com26 Apr 2023

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.

DRL, 1st Indian company to supply generic drugs to China's state hospitals

DRL, 1st Indian company to supply generic drugs to China's state hospitals

Rediff.com27 Sep 2019

The drug that it would supply is called Olanzapine, used to treat schizophrenia and bipolar disorder.

Sensex ends in green for 3rd straight day; ends up 790 points

Sensex ends in green for 3rd straight day; ends up 790 points

Rediff.com28 Apr 2021

Bajaj Finance was the top gainer in the Sensex pack, soaring around 8 per cent, followed by IndusInd Bank, Bajaj Finserv, ICICI Bank, Kotak Bank, SBI, Bajaj Auto and HDFC Bank. NSE Nifty surged 211.50 points to 14,864.55.

Investors' wealth jumps over Rs 2.51 lakh cr as stocks rebound

Investors' wealth jumps over Rs 2.51 lakh cr as stocks rebound

Rediff.com8 Mar 2022

Investors' wealth on Tuesday jumped by over Rs 2.51 lakh crore, in tandem with a sharp recovery in equities after four days of heavy declines. The 30-share BSE Sensex opened on a weak note and tumbled 581.93 points or 1.10 per cent to 52,260.82 during the day amid firming oil prices and relentless selling by foreign institutional investors. Amid bouts of volatility, the benchmark touched a high of 53,484.26 and a low of 52,260.82 during the trade. It finally settled at 53,424.09, higher by 581.34 points or 1.10 per cent.

Dream for a new party dashed with Reddy's arrest

Dream for a new party dashed with Reddy's arrest

Rediff.com6 Sep 2011

The dream run for Janardhan Reddy has come to an end with his arrest by the Central Bureau of Investigation on Monday. However, the big question that is being asked is were these raids a long shot at the rising prospects of Jagan Mohan Reddy, the son of the late Andhra Pradesh Chief Minister Dr Y Rajasekara Reddy? Reports Vicky Nanjappa

These Scientists Shaped India

These Scientists Shaped India

Rediff.com15 Aug 2023

I suggest we build a Vigyan Mandir (Temple of Science) with the ambience of a place of worship, so that it becomes a destination for pilgrims. We should embed on its walls bronze plaques describing each scientist mentioned here along with about a dozen of our ancient mathematicians, recommends Professor Kalyan Singhal, historian of science and technology.

Kin of COVID-19 patients refuse to take them home after recovery

Kin of COVID-19 patients refuse to take them home after recovery

Rediff.com30 Jun 2020

Some of the recovered patients are aged people, including a 93-year old woman and are still in Gandhi Hospital while the rest have been sent to different facilities.

India eyes oil-for-drugs deal with Venezuela to recoup pharma cash

India eyes oil-for-drugs deal with Venezuela to recoup pharma cash

Rediff.com18 May 2016

Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency

Sensex, Nifty sparkle as Samvat 2079 begins on auspicious note

Sensex, Nifty sparkle as Samvat 2079 begins on auspicious note

Rediff.com24 Oct 2022

Market benchmark BSE Sensex rallied 635 points to 59,942 in the opening trade of the special Muhurat session on Monday to mark the beginning of Hindu Samvat year 2079. The 30-share index was trading higher by 635.12 points, or 1.07 per cent, at 59,942.27 in the first few minutes of trade. Similarly, the broader NSE Nifty surged 192.20 points or 1.09 per cent to 17,768.50.

Index heavyweights drag Sensex down 189 points

Index heavyweights drag Sensex down 189 points

Rediff.com28 Jun 2021

Titan was the top loser in the Sensex pack, shedding over 1 per cent, followed by TCS, HCL Tech, Reliance Industries, UltraTech Cement and Bharti Airtel. NSE Nifty settled 45.65 points down at 15,814.70.

Sensex spurts 389 points as oil, metal stocks recover

Sensex spurts 389 points as oil, metal stocks recover

Rediff.com28 Feb 2022

Among major Sensex movers, Reliance Industries soared by 3.29 per cent as energy prices rose due to the war in Ukraine. Tata Steel emerged as the lead gainer among Sensex scrips, jumping by 6.61 per cent. Power Grid, Titan, NTPC, ICICI Bank, L&T, Infosys and Sun Pharma were among the gainers.

2nd Covid wave spooks investors; Sensex plunges 1,708 points

2nd Covid wave spooks investors; Sensex plunges 1,708 points

Rediff.com12 Apr 2021

IndusInd Bank was the top loser in the Sensex pack, tanking over 8 per cent, followed by Bajaj Finance, SBI, ONGC, Titan, M&M, Bajaj Finserv, ICICI Bank and Axis Bank. NSE Nifty plunged 524.05 points to finish at 14,310.80.

The Many Firsts Of Droupadi Murmu

The Many Firsts Of Droupadi Murmu

Rediff.com22 Jun 2022

When elected on July 18 -- which is almost a certainty, given the NDA's numbers in the electoral college -- Droupadi Murmu will be the first President born after Independence.

India's pharma industry likely to take 5-6% price hikes this year

India's pharma industry likely to take 5-6% price hikes this year

Rediff.com6 Sep 2023

Notwithstanding the fact that the country's pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential Medicines (NLEM) in 2023, analysts and industry insiders predict that the overall domestic pharma industry will only witness a price hike of 5-6 per cent. This is attributed to higher competitive intensity in the market. Krishnakumar V, executive director and chief operating officer (CEO) of Eris Lifesciences, a domestic-focused pharma company, noted that the NLEM segment experienced growth suppression of around 150 basis points due to price reductions during the January to July period this year.

PHOTOS: India ride on Jaiswal ton as other batters falter

PHOTOS: India ride on Jaiswal ton as other batters falter

Rediff.com2 Feb 2024

'I wanted to convert the loose balls, and play till the end.'

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Rediff.com7 Aug 2023

Trade generic drugs (medicines that are sold directly through distributors) are fast becoming a key segment for domestic pharma firms as volume growth slows in the overall market. Big companies like Cipla and Alkem have a significant presence in the segment but recently, players like Torrent Pharmaceuticals and Dr Reddy's Laboratories (DRL) have also entered this market. What is driving big pharma's focus on trade generics? The volume growth in the Indian Pharma Market (IPM) has come down from 5.6 per cent in FY16 to 0.1 per cent in FY23.